Articles by Daniel Carlat, MD

Fact Sheet

Bremelanotide (Vyleesi) Fact Sheet

January 1, 2026

Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Bremelanotide (marketed as the “female Viagra”) is a melanocortin receptor agonist that is modestly effective in increasing sexual desire in premenopausal women, though it doesn’t affect sexual functioning.

Fact Sheet

Avanafil (Stendra) Fact Sheet

January 1, 2026

Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Avanafil is a phosphodiesterase type 5 (PDE-5) inhibitor with the advantage of having a somewhat faster onset than any of the other erectile dysfunction (ED) drugs.

Treatment Algorithm

Psychosis Treatment Algorithm

January 1, 2026

Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Psychosis Treatment Algorithm

Patient Sheet

Subjective Opiate Withdrawal Scale (SOWS) Fact Sheet for Patients

January 1, 2026

Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

The Subjective Opiate Withdrawal Scale (SOWS) is a scale that can be used to define the severity of opioid withdrawal symptoms at home without the involvement of a health care provider.

Patient Sheet

Opioid Overdose Overview Fact Sheet for Patients

January 1, 2026

Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Opioids can cause a bad and potentially fatal reaction (overdose) that makes your breathing slow or even stop, which can be fatal.

Patient Sheet

Personal Recovery Plan Template Fact Sheet for Patients

January 1, 2026

Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Fill out this sheet with your provider in order to put together a personal recovery plan.

Patient Sheet

Alcohol Use Disorder: Personal Recovery Plan Template

January 1, 2026

Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Patient Sheet

Olanzapine (Zyprexa) Fact Sheet for Patients

January 1, 2026

Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Olanzapine is used to treat certain mental/mood conditions such as schizophrenia, bipolar disorder, and depression in combination with other medications.

Patient Sheet